Core Viewpoint - Nanjing Hailin Pharmaceutical Co., Ltd. is preparing for the election of its fifth board of directors, following the completion of the fourth board's term, in accordance with relevant laws and regulations [1][2]. Group 1: Board Composition - The fifth board of directors will consist of 7 members, including 4 non-independent directors and 3 independent directors, with one non-independent director elected by the employee representative assembly [2]. - The candidates for the fifth board include Cao Yuping, Cao Xicheng, and Feng Mingsheng as non-independent directors, and Lu Tao, Mao Lingxiao, and Wang Yuchun as independent directors [2][3]. Group 2: Candidate Qualifications - All candidates have been vetted and meet the qualifications required by the Company Law and the company's articles of association [2][5]. - Independent director candidates Lu Tao, Mao Lingxiao, and Wang Yuchun have obtained independent director qualification certificates recognized by the Shenzhen Stock Exchange [2][7][9]. Group 3: Election Process - The election of the fifth board of directors will be submitted to the company's first extraordinary general meeting of 2025 for approval, using a cumulative voting system [2][3]. - The term for the new board members will last for three years from the date of approval at the extraordinary general meeting [3]. Group 4: Candidate Profiles - Cao Yuping, born in 1964, holds a master's degree and has extensive experience in the pharmaceutical industry, currently serving as the chairman and general manager of the company [3][4]. - Cao Xicheng, born in 1994, is a master's degree holder and the son of Cao Yuping, currently serving as a director of the company [5]. - Feng Mingsheng, born in 1978, holds a doctoral degree and is currently the deputy manager of the new drug department [6]. - Lu Tao, born in 1963, is a pharmaceutical expert with a doctoral degree and has served in various academic roles [7]. - Mao Lingxiao, born in 1964, is a senior lawyer with extensive legal experience and currently serves as an independent director [8]. - Wang Yuchun, born in 1956, is a professor of accounting with a master's degree and has served as an independent director for other companies [9].
海辰药业: 关于董事会换届选举的公告